ValuentumAd

Official PayPal Seal

Discuss: Taxes and the Future of American Business

publication date: Nov 23, 2015
 | 
author/source: Valuentum Editorial Staff
Previous | Next
 

Image Source: Montgomery County

Tax inversion deals are back on. And in a big way!

Pharma giant Pfizer (PFE) and Allergan (AGN) announced the largest one, creating the biggest drug maker by revenue in the combination, one that will headquarter in Ireland for tax purposes. Do US tax holders truly believe they own the companies? Or are tax inversions a part of American freedom, championed on a global stage?

What do you think? Comment below.


-------------------------------------------------
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Valuentum Exclusive publication, ESG Newsletter, and any reports, data and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, data or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, and independent contractors may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, ESG Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Valuentum Exclusive publication and additional options commentary feature, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.